title: 2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations.
abstract: The present article is a summary of the theme, the key recommendations for management of hypertension and the supporting clinical evidence of the 2010 Canadian Hypertension Education Program (CHEP). In 2010, CHEP emphasizes the need for health care professionals to stay informed about hypertension through automated updates at www.htnupdate.ca. A new interactive Internet-based lecture series will be available in 2010 and a program to train community hypertension leaders will be expanded. Patients can also sign up to receive regular updates in a pilot program at www.myBPsite.ca. In 2010, the new recommendations include consideration for using automated office blood pressure monitors, new targets for dietary sodium for the prevention and treatment of hypertension that are aligned with the national adequate intake values, and recommendations for considering treatment of selected hypertensive patients at high risk with calcium channel blocker/angiotensin-converting enzyme inhibitor combinations and the use of angiotensin receptor blockers.
authors.affiliation: Department of Medicine, University of Calgary, Alberta. ncampbel@ucalgary.ca
authors.forename: Norman R C
authors.initials: NR
authors.lastname: Campbell
authors.forename: Janusz
authors.initials: J
authors.lastname: Kaczorowski
authors.forename: Richard Z
authors.initials: RZ
authors.lastname: Lewanczuk
authors.forename: Ross
authors.initials: R
authors.lastname: Feldman
authors.forename: Luc
authors.initials: L
authors.lastname: Poirier
authors.forename: Margaret Moy
authors.initials: MM
authors.lastname: Kwong
authors.forename: Marcel
authors.initials: M
authors.lastname: Lebel
authors.forename: Finlay A
authors.initials: FA
authors.lastname: McAlister
authors.forename: Sheldon W
authors.initials: SW
authors.lastname: Tobe
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002170:Canada; D004039:Diet, Sodium-Restricted; D005260:Female; D006293:Health Promotion; D006801:Humans; D006973:Hypertension / Q000517:prevention & control* / Q000628:therapy; D008019:Life Style; D008297:Male; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D040242:Risk Reduction Behavior
chemical_list: D000959:Antihypertensive Agents